MLAB - Mesa Laboratories, Inc.
IEX Last Trade
133.89
-0.149 -0.111%
Share volume: 33,431
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$134.04
-0.15
-0.11%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 2022-08-04 | 2022-11-03 | 2023-02-06 | 2023-05-30 | 2023-08-03 | 2023-11-06 | 2024-02-05 | 2024-06-28 | |
| Assets | |||||||||
| Total Assets | 685.811 M | 656.231 M | 662.984 M | 661.832 M | 642.611 M | 637.188 M | 741.769 M | 446.796 M | |
| Current Assets | 128.127 M | 116.260 M | 114.185 M | 118.975 M | 114.808 M | 117.662 M | 118.355 M | 109.352 M | |
| Inventories | 26.874 M | 28.039 M | 33.739 M | 34.642 M | 35.559 M | 32.879 M | 35.973 M | 32.675 M | |
| Other Current Assets | 15.666 M | 14.035 M | 11.950 M | 8.872 M | 11.278 M | 12.826 M | 18.135 M | 9.408 M | |
| Short Term Investments | 15.666 M | 14.035 M | 11.950 M | 8.872 M | 11.278 M | 12.826 M | 18.135 M | 9.408 M | |
| Total Receivables | 41.840 M | 41.809 M | 42.395 M | 42.551 M | 35.595 M | 36.340 M | 36.023 M | 39.055 M | |
| Current Cash | 43.747 M | 32.377 M | 26.101 M | 32.910 M | 32.376 M | 35.617 M | 28.224 M | 28.214 M | |
| Total Non-current Assets | 557.684 M | 539.971 M | 548.799 M | 542.857 M | 527.803 M | 519.526 M | 623.414 M | 337.444 M | |
| Property Plant Equipment | 28.006 M | 28.222 M | 28.263 M | 28.149 M | 27.953 M | 28.574 M | 31.775 M | 31.766 M | |
| Other Assets | 10.424 M | 10.825 M | 10.572 M | 10.373 M | 9.623 M | 8.953 M | 11.590 M | 10.538 M | |
| Intangible Assets | 235.000 M | 222.271 M | 223.447 M | 216.815 M | 205.394 M | 197.680 M | 232.774 M | 113.752 M | |
| Goodwill | 283.565 M | 278.006 M | 285.809 M | 286.444 M | 283.756 M | 283.268 M | 346.183 M | 180.096 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 685.811 M | 656.231 M | 662.984 M | 661.832 M | 642.611 M | 637.188 M | 741.769 M | 446.796 M | |
| Total liabilities | 305.380 M | 281.995 M | 275.779 M | 268.352 M | 254.892 M | 249.429 M | 338.808 M | 301.403 M | |
| Total current liabilities | 44.127 M | 41.506 M | 41.617 M | 43.359 M | 39.126 M | 39.816 M | 44.183 M | 44.312 M | |
| Accounts Payable | 7.557 M | 7.738 M | 6.288 M | 6.134 M | 5.588 M | 4.810 M | 4.554 M | 6.041 M | |
| Other liabilities | 7.340 M | 6.826 M | 8.172 M | 7.693 M | 6.757 M | 5.443 M | 17.320 M | 15.613 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 216.590 M | 196.816 M | 189.044 M | 183.272 M | 175.502 M | 170.733 M | 232.965 M | 221.698 M | |
| Other liabilities | 7.340 M | 6.826 M | 8.172 M | 7.693 M | 6.757 M | 5.443 M | 17.320 M | 15.613 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 380.431 M | 374.236 M | 387.205 M | 393.480 M | 387.719 M | 387.759 M | 402.961 M | 145.393 M | |
| Common stock | 5.273 M | 5.323 M | 5.339 M | 5.349 M | 5.372 M | 5.387 M | 5.393 M | 5.392 M | |
| Retained earnings | 74.394 M | 74.848 M | 74.444 M | 74.199 M | 72.791 M | 70.699 M | 71.953 M | -183.494 M |